Rethinking Clinical Trials

JANUARY 31, 2024

Tags #pctGR, @Collaboratory1 The post Grand Rounds January 26, 2024: Advancing the Safe, Effective and Equitable Use of AI in Healthcare (Mark Sendak, MD, MPP; Suresh Balu, MD, MBA) appeared first on Rethinking Clinical Trials. – How do you get reliable information and data for care that is received outside of Duke?

Production 161

Production Development Clinical Trials Clinical Trials 161

Rethinking Clinical Trials

AUGUST 10, 2023

Tags #pctGR, @Collaboratory1 The post Grand Rounds August 4, 2023: AI & ML: Want to Play a Game? However, these new technologies are more likely to replace people who can’t use the new technologies. The important thing is to learn and adapt to the changes. Eric Perakslis, PhD) appeared first on Rethinking Clinical Trials.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Medicine 130

XTalks

DECEMBER 21, 2022

The multi-million-dollar price tags are largely attributable to the high R&D and manufacturing costs associated with making a gene therapy, as the raw materials for producing the therapy can be expensive. AI/ML Technology. Currently, CSL Behring’s one-dose Hemophilia B gene therapy Hemgenix holds the title at $3.5

Life Science 52

Life Science Gene Therapy Gene Clinical Trials 52

Rethinking Clinical Trials

FEBRUARY 2, 2023

The PrePARE Trial tested the initiation of a 500 mL crystalloid fluid bolus before induction in 9 U.S. Tags #pctGR, @Collaboratory1 The post Grand Rounds January 27, 2023: The PREPARE II Trial: Embedding a Pragmatic Trial Into Clinical Care During an Emergency Procedure (Derek W. This results in arbitrary variation in clinical care.

Trials 130

Trials Clinical Trials Clinical Trials Medicine 130

Drug Discovery World

NOVEMBER 13, 2023

Novel/alternative ML-enabled screening technologies for higher POS Following chairperson’s remarks from M Frank Erasmus, PhD, Head, Bioinformatics, Specifica, there will be four presentations and a panel discussion. The panel discussion will be hosted by chairperson Erasmus and Greiff on the current state of AI in antibody therapeutics.

Protein 59

Protein Antibody Engineer Scientist 59

Drug Discovery World

NOVEMBER 9, 2023

Esperanza Rivera de Torre, PhD, Assistant Professor, Center for Antibody Technologies, Department of Bioengineering, Technical University of Denmark, on: ‘Venom on demand: optimising snake toxin yield, folding, and purity in E coli and P pastoris with biotinylation, solubility, and purification tags’. Crystal Richardson, Ph.D,

Engineer 52

Engineer Antibody Protein In-Vivo 52